C. Thivolet

1.3k total citations
28 papers, 839 citations indexed

About

C. Thivolet is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, C. Thivolet has authored 28 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Surgery and 14 papers in Genetics. Recurrent topics in C. Thivolet's work include Diabetes and associated disorders (13 papers), Diabetes Management and Research (12 papers) and Pancreatic function and diabetes (12 papers). C. Thivolet is often cited by papers focused on Diabetes and associated disorders (13 papers), Diabetes Management and Research (12 papers) and Pancreatic function and diabetes (12 papers). C. Thivolet collaborates with scholars based in France, Germany and Norway. C. Thivolet's co-authors include B. Vialettes, P. Fontaine, Valerie Grange, Pierre Bougnères, V. Kerlan, P Passa, B Charbonnel, Pierre Drouin, Bruno Guerci and F. Rouberol and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Diabetes and Annals of the New York Academy of Sciences.

In The Last Decade

C. Thivolet

26 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Thivolet France 14 486 306 262 83 81 28 839
Elisabeth Björk Sweden 11 363 0.7× 336 1.1× 270 1.0× 88 1.1× 63 0.8× 12 640
Ana Pinheiro Machado Canton Brazil 18 167 0.3× 243 0.8× 98 0.4× 122 1.5× 291 3.6× 37 894
Mette K. Andersen Denmark 17 243 0.5× 318 1.0× 191 0.7× 16 0.2× 181 2.2× 46 779
K Frost-Larsen Denmark 15 273 0.6× 100 0.3× 147 0.6× 361 4.3× 104 1.3× 30 999
E. Schifferdecker Germany 10 127 0.3× 99 0.3× 40 0.2× 49 0.6× 72 0.9× 29 375
B R Rowe United Kingdom 12 189 0.4× 211 0.7× 142 0.5× 9 0.1× 70 0.9× 15 509
J. Lyngsøe Denmark 11 430 0.9× 601 2.0× 387 1.5× 15 0.2× 132 1.6× 29 1.0k
Nicola Locuratolo Italy 12 123 0.3× 27 0.1× 90 0.3× 56 0.7× 134 1.7× 22 506
Steven Orlov Canada 13 235 0.5× 29 0.1× 155 0.6× 117 1.4× 13 0.2× 15 627
Stephen O’Riordan United Kingdom 12 234 0.5× 185 0.6× 157 0.6× 12 0.1× 113 1.4× 17 709

Countries citing papers authored by C. Thivolet

Since Specialization
Citations

This map shows the geographic impact of C. Thivolet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Thivolet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Thivolet more than expected).

Fields of papers citing papers by C. Thivolet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Thivolet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Thivolet. The network helps show where C. Thivolet may publish in the future.

Co-authorship network of co-authors of C. Thivolet

This figure shows the co-authorship network connecting the top 25 collaborators of C. Thivolet. A scholar is included among the top collaborators of C. Thivolet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Thivolet. C. Thivolet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marchand, Lucien, et al.. (2018). Very high titres of ZnT8 autoantibodies at type 1 diabetes onset and presence of autoantibodies related to other autoimmune disorders. Diabetes & Metabolism. 46(1). 73–74. 3 indexed citations
2.
Chesi, Alessandra, Jonathan P. Bradfield, Håkon Håkonarson, et al.. (2015). GWAS-implicated in type 1 and type 2 diabetes loci:insight into their relative roles in the pathogenesis of Latent Autoimmune Diabetes in Adults (LADA). University of Southern Denmark Research Portal (University of Southern Denmark). 1 indexed citations
3.
Disse, Emmanuel, Marc Claret, Anne Charrié, et al.. (2015). Are third-trimester adipokines associated with higher metabolic risk among women with gestational diabetes?. Diabetes & Metabolism. 41(5). 393–400. 11 indexed citations
4.
Betry, Cécile, Anne Charrié, Jocelyne Drai, et al.. (2014). Increased TSH in obesity: Evidence for a BMI-independent association with leptin. Diabetes & Metabolism. 41(3). 248–251. 76 indexed citations
5.
Canouï‐Poitrine, Florence, et al.. (2010). Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy. Diabetes & Metabolism. 36(2). 152–157. 48 indexed citations
6.
7.
Aptel, Florent, P. Denis, F. Rouberol, & C. Thivolet. (2008). Screening of diabetic retinopathy: Effect of field number and mydriasis on sensitivity and specificity of digital fundus photography. Diabetes & Metabolism. 34(3). 290–293. 69 indexed citations
8.
Guerci, Bruno, Pierre Drouin, Valerie Grange, et al.. (2003). Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes & Metabolism. 29(6). 587–594. 207 indexed citations
9.
Chapelle, J.-P., P Drouin, Claire Lévy‐Marchal, et al.. (2000). Hemoglobin A1C assays and hemoglobinopathies : problems and strategies. Annales de biologie clinique. 58(4). 1 indexed citations
10.
Thivolet, C., X. Martin, N Lefrançois, et al.. (2000). SEROLOGICAL MARKERS OF RECURRENT BETA CELL DESTRUCTION IN DIABETIC PATIENTS UNDERGOING PANCREATIC TRANSPLANTATION. Transplantation. 69(1). 99–99. 32 indexed citations
11.
Gillery, Philippe, P Drouin, Claire Lévy‐Marchal, et al.. (2000). [Hemoglobin A1C determination and hemoglobinopathies: problems and strategies].. PubMed. 58(4). 425–9. 14 indexed citations
12.
Drouin, P, Claire Lévy‐Marchal, C. Périer, et al.. (1999). HbA1c: concertation clinico-biologique pour la standardisation des méthodes de dosage. Rapport des experts de l'ALFEDIAM et de la SFBC.. Diabetes & Metabolism. 25(3). 3 indexed citations
13.
Bergerot, Isabelle, Nicole Fabien, A. Mayer, & C. Thivolet. (1996). Active Suppression of Diabetes after Oral Administration of Insulin Is Determined by Antigen Dosage. Annals of the New York Academy of Sciences. 778(1). 362–367. 20 indexed citations
14.
Bergerot, Isabelle, Nicole Fabien, & C. Thivolet. (1996). Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.. PubMed. 22(4). 235–9. 7 indexed citations
15.
Honnorat, Jérôme, P Trouillas, C. Thivolet, M. Aguera, & Marie‐Françoise Belin. (1995). Autoantibodies to Glutamate Decarboxylase in a Patient With Cerebellar Cortical Atrophy, Peripheral Neuropathy, and Slow Eye Movements. Archives of Neurology. 52(5). 462–468. 53 indexed citations
16.
Thivolet, C., Marcel Tappaz, A. Durand, et al.. (1992). Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of Type 1 (insulin-dependent) diabetes mellitus in high risk individuals. Diabetologia. 35(6). 570–576. 56 indexed citations
17.
18.
19.
Thivolet, C., et al.. (1990). Proliferative retinopathy in a woman with growth hormone deficiency and diabetes mellitus.. BMJ. 300(6730). 979–980. 4 indexed citations
20.
Thivolet, C., G Mauduit, B Canivet, et al.. (1988). [Acanthosis nigricans, hyperandrogenism, insulin resistance and mixed hyperlipemia].. PubMed. 17(26). 1355–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabeth Björk Breakdown of academic impact, for papers by Ana Pinheiro Machado Canton Breakdown of academic impact, for papers by Mette K. Andersen Breakdown of academic impact, for papers by K Frost-Larsen Breakdown of academic impact, for papers by E. Schifferdecker Breakdown of academic impact, for papers by B R Rowe Breakdown of academic impact, for papers by J. Lyngsøe Breakdown of academic impact, for papers by Nicola Locuratolo Breakdown of academic impact, for papers by Steven Orlov Breakdown of academic impact, for papers by Stephen O’Riordan
Rankless by CCL
2026